Equine verminous arteritis. An arteriographic evaluation of the larvicidal activity of albendazole.

This study examines the effectiveness of the drug Albendazole in treating infestations of a specific type of worm larvae (Strongylus vulgaris) in horses. It shows that the drug can effectively kill these larvae, but it may also cause side effects like diarrhea, which led to dehydration and death in one case.

Research Methodology and Experiment Execution

• The scholars conducted their study on foals (baby horses), some of which were infected with the fourth stage of Strongylus vulgaris larvae.
• They administered Albendazole, a known anthelmintic (parasite-killing) drug, to the infected foals. The dosage given was 25 milligrams per kilogram of body weight, delivered three times daily for five days.
• The team subsequently tracked the development and regression of lesions in the treated foals, comparing their progress with that of infected foals that did not receive treatment. This provided a comparative analysis of disease progression with and without the intervention of Albendazole treatment.

Key Findings

• The researchers discovered the effectiveness of Albendazole as a larvicidal agent—which means it effectively killed Strongylus vulgaris larvae—even when administered a month post-infection.
• They made broader observations related to side effects, noting that of the 4 foals treated, 3 had diarrhea as a result of the drug. Of those three, one died due to dehydration—initiating intravenous therapy for dehydration was insufficient to save this foal. This highlights potential risks associated with the use of Albendazole.
• Arteriography, a diagnostic imaging technique that visualizes the inside of blood vessels, provided crucial data for the in-vivo (within living) assessment of lesions’ development and regression as a result of the treatment. This comparison showed positive impacts of Albendazole on disease progression.
• Findings from the arteriography were later confirmed at necropsy (animal autopsy) creating a synergistic validation of the drug’s effectiveness against Strongylus vulgaris larvae.

Implications

This study is a noteworthy contribution to the field as it not only confirms the effectiveness of Albendazole against the fourth-stage Strongylus vulgaris larvae in horses, but also highlights the potential risk factors associated with its use. It implies that while Albendazole can serve as an effective tool for managing infestations in horses, vets and caretakers should monitor animals closely for potential side effects such as diarrhea. Further studies should focus on minimizing these side effects.